By Josh White
Date: Friday 05 Dec 2025
(Sharecast News) - Genedrive reported a doubling of revenue and other income to £1m for the year ended 30 June on Friday, from £0.5m a year earlier, as the point-of-care pharmacogenetic testing company shifted from a pre-commercial to a commercial focus.
The AIM-traded firm said its loss after tax narrowed to...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news